doxazosin has been researched along with Pheochromocytoma in 37 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The literature was reviewed by searching PubMed using the following search terms: pheochromocytoma, phenoxybenzamine, doxazosin and alpha-blockade." | 8.90 | Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin. ( de Boer, A; van der Zee, PA, 2014) |
| "No conclusion exists for the optimum duration of preoperative administration of doxazosin (DOX) before adrenalectomy for pheochromocytoma." | 7.96 | The use of doxazosin before adrenalectomy for pheochromocytoma: is the duration related to intraoperative hemodynamics and postoperative complications? ( Bao, Z; Fang, D; Gao, Y; Jin, B; Kong, H; Li, N; Liu, L; Tian, J; Wu, K; Zhang, J; Zhang, Z; Zhou, L, 2020) |
| "To compare phenoxybenzamine (PhB) and doxazosin (DOX) in terms of perioperative haemodynamic status in patients with pheochromocytoma, who have been prepared for adrenalectomy." | 7.85 | Comparison of phenoxybenzamine and doxazosin in perioperative management of patients with pheochromocytoma. ( Ambroziak, U; Bednarczuk, T; Gałązka, Z; Kącka, A; Krajewska, E; Malec, K; Miśkiewicz, P; Piotrowski, M; Toutounchi, S; Witkowska, A, 2017) |
| "Authors evaluated the effects of selective adrenergic blockade by means of doxazosin on blood pressure in 48 patients operated on for pheochromocytoma by a multicenter retrospective study." | 7.79 | Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma: a retrospective study of 48 cases. ( Agostino-Sinisi, A; Conzo, G; Corcione, F; Della-Pietra, C; Depalma, M; Ferraro, F; Milone, M; Musella, M; Napolitano, S; Palazzo, A; Pasquali, D; Santini, L; Stanzione, F, 2013) |
| "To compare the effects of doxazosin mosylate and phenoxybenzamine in preoperative volume expansion of pheochromocytoma." | 7.73 | [Effects of doxazosin mosylate and phenoxybenzamine in preoperative volume expansion of pheochromocytoma: a comparative study in 38 cases]. ( Ji, ZG; Li, HZ; Pan, DL; Zeng, ZP, 2005) |
| "Doxazosin (2-16 mg/day) was as effective as phenoxybenzamine in controlling arterial pressure and heart rate before and during surgery, but doxazosin caused fewer undesirable side effects both before and after surgery." | 6.70 | Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. ( Farndon, JR; Prys-Roberts, C, 2002) |
| "Doxazosin monotherapy was effective in eight of 12 patients (66." | 6.66 | Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma. ( Miura, Y; Yoshinaga, K, 1988) |
| "Pheochromocytoma is a catecholamine-secreting tumor, for which the treatment of choice is complete surgical resection, when possible." | 5.36 | Alpha blockade with doxazosin in pheochromocytoma--report of three cases. ( Carvalho, MR; Dias, T; do Carmo, I; Esteves, R; Machado, AP; Rodrigues, A, 2010) |
| "The objective of this article is to evaluate the efficacy of Doxazosin Mesylate Controlled Release Tablets for preoperative treatment of patients with pheochromocytoma." | 5.14 | Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma. ( He, HC; Ning, G; Rui, WB; Shen, Z; Su, TW; Sun, FK; Wang, WQ; Wu, YX; Zhang, CY; Zhao, JP; Zhou, WL; Zhu, Y, 2010) |
| "The literature was reviewed by searching PubMed using the following search terms: pheochromocytoma, phenoxybenzamine, doxazosin and alpha-blockade." | 4.90 | Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin. ( de Boer, A; van der Zee, PA, 2014) |
| " In this article, doxazosin is reviewed for its efficacy in the treatment of severe essential hypertension and specific complications or conditions of mild or moderate essential hypertension, namely, left ventricular hypertrophy, hyperlipidemia, noninsulin-dependent diabetes mellitus, renal insufficiency, pheochromocytoma, chronic obstructive pulmonary disease, peripheral vascular disease, and smoking." | 4.78 | Efficacy of doxazosin in specific hypertensive patient groups. ( Taylor, SH, 1991) |
| "Phenoxybenzamine (nonselective, noncompetitive alpha-blocker) is the preferred drug for preoperative treatment of pheochromocytoma, but doxazosin (selective, competitive alpha-blocker) may be equally effective." | 4.12 | Comparison of Preoperative Alpha-blockade for Resection of Paraganglioma and Pheochromocytoma. ( Hong, JC; Hu, MY; Isorena, J; Kamdar, NV; Kuo, EJ; Lee, JS; Livhits, MJ; Tseng, CH; Yeh, MW; Yu, R; Zhu, CY, 2022) |
| "No conclusion exists for the optimum duration of preoperative administration of doxazosin (DOX) before adrenalectomy for pheochromocytoma." | 3.96 | The use of doxazosin before adrenalectomy for pheochromocytoma: is the duration related to intraoperative hemodynamics and postoperative complications? ( Bao, Z; Fang, D; Gao, Y; Jin, B; Kong, H; Li, N; Liu, L; Tian, J; Wu, K; Zhang, J; Zhang, Z; Zhou, L, 2020) |
| "To compare phenoxybenzamine (PhB) and doxazosin (DOX) in terms of perioperative haemodynamic status in patients with pheochromocytoma, who have been prepared for adrenalectomy." | 3.85 | Comparison of phenoxybenzamine and doxazosin in perioperative management of patients with pheochromocytoma. ( Ambroziak, U; Bednarczuk, T; Gałązka, Z; Kącka, A; Krajewska, E; Malec, K; Miśkiewicz, P; Piotrowski, M; Toutounchi, S; Witkowska, A, 2017) |
| "Authors evaluated the effects of selective adrenergic blockade by means of doxazosin on blood pressure in 48 patients operated on for pheochromocytoma by a multicenter retrospective study." | 3.79 | Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma: a retrospective study of 48 cases. ( Agostino-Sinisi, A; Conzo, G; Corcione, F; Della-Pietra, C; Depalma, M; Ferraro, F; Milone, M; Musella, M; Napolitano, S; Palazzo, A; Pasquali, D; Santini, L; Stanzione, F, 2013) |
| "To compare the effects of doxazosin mosylate and phenoxybenzamine in preoperative volume expansion of pheochromocytoma." | 3.73 | [Effects of doxazosin mosylate and phenoxybenzamine in preoperative volume expansion of pheochromocytoma: a comparative study in 38 cases]. ( Ji, ZG; Li, HZ; Pan, DL; Zeng, ZP, 2005) |
| "Phenoxybenzamine was more effective in preventing intraoperative hemodynamic instability, but it could not be established whether this was associated with a better clinical outcome." | 2.94 | Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial. ( Bisschop, PHLT; Buitenwerf, E; Corssmit, EPM; Dullaart, RPF; Eekhoff, EMW; Feelders, RA; Haak, HR; Kerstens, MN; Lenders, JWM; Links, TP; Osinga, TE; Timmers, HJLM; Valk, GD; Veldman, RG; Voogd, MF; Wietasch, GJKG, 2020) |
| "Surgical treatment of pheochromocytoma is associated with a high risk of hemodynamic instability." | 2.79 | Perioperative sequential monitoring of hemodynamic parameters in patients with pheochromocytoma using the Non-Invasive Cardiac System (NICaS). ( Adachi, M; Kawate, H; Matsuda, Y; Matsuzaki, C; Nagata, H; Nomura, M; Ohnaka, K; Shimada, S; Takayanagi, R, 2014) |
| "Doxazosin (2-16 mg/day) was as effective as phenoxybenzamine in controlling arterial pressure and heart rate before and during surgery, but doxazosin caused fewer undesirable side effects both before and after surgery." | 2.70 | Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. ( Farndon, JR; Prys-Roberts, C, 2002) |
| "Doxazosin monotherapy was effective in eight of 12 patients (66." | 2.66 | Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma. ( Miura, Y; Yoshinaga, K, 1988) |
| "In conclusion, intraoperative complications in pheochromocytoma surgery are common and can be potentially life-threatening." | 1.62 | Risk factors for intraoperative complications in pheochromocytomas. ( Álvarez-Escolá, C; Araujo-Castro, M; Blanco-Carrera, C; Calatayud Gutiérrez, M; de Miguel Novoa, P; Fernández-Ladreda, MT; Garcia Centeno, R; Gómez Dos Santos, V; Gracia Gimeno, P; Hanzu, FA; Lamas, C; López-García, MC; Mínguez Ojeda, C; Mora, M; Percovich Hualpa, JC; Serrano Romero, A; Valdés, N; Vidal, Ó, 2021) |
| "doxazosin) was performed in 35 % (n = 18) of patients, and non-selective blockade with phenoxybenzamine was performed in 65 % (n = 34) of patients." | 1.46 | Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma. ( Balentine, CJ; Pitt, SC; Randle, RW; Schneider, DF; Sippel, RS, 2017) |
| "As a surgical treatment of pheochromocytomas, laparoscopic adrenalectomy is an effective and safe approach, in selected cases even for PCCs >6 cm in diameter, although patients with such large tumors may have a higher conversion rate and more intraoperative hypertensive crises." | 1.39 | Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series. ( Colantuoni, V; Conzo, G; Corcione, F; De Palma, M; Ferraro, F; Milone, M; Musella, M; Napolitano, S; Palazzo, A; Pasquali, D; Santini, L; Sinisi, AA, 2013) |
| "Pheochromocytoma is a catecholamine-secreting tumor, for which the treatment of choice is complete surgical resection, when possible." | 1.36 | Alpha blockade with doxazosin in pheochromocytoma--report of three cases. ( Carvalho, MR; Dias, T; do Carmo, I; Esteves, R; Machado, AP; Rodrigues, A, 2010) |
| "A 29-year-old man had been treated for hypertension for 10 years." | 1.35 | [Ejaculatory disorder caused by doxazosin administration for blood pressure control in patient with pheochomocytoma]. ( Amano, T; Imao, T; Takemae, K; Yamauchi, K, 2009) |
| "Pheochromocytoma is associated with intense physiologic effects of alpha- and beta-adrenergic stimulation from catecholamine secretion." | 1.33 | The perioperative management of a patient with complex single ventricle physiology and pheochromocytoma. ( McGowan, FX; Seefelder, C; Shamberger, RC; Sparks, JW, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.70) | 18.7374 |
| 1990's | 2 (5.41) | 18.2507 |
| 2000's | 11 (29.73) | 29.6817 |
| 2010's | 17 (45.95) | 24.3611 |
| 2020's | 6 (16.22) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, CY | 1 |
| Hong, JC | 1 |
| Kamdar, NV | 1 |
| Hu, MY | 1 |
| Tseng, CH | 1 |
| Lee, JS | 1 |
| Kuo, EJ | 1 |
| Yu, R | 1 |
| Isorena, J | 1 |
| Yeh, MW | 1 |
| Livhits, MJ | 1 |
| De Filpo, G | 1 |
| Parenti, G | 1 |
| Sparano, C | 1 |
| Rastrelli, G | 1 |
| Rapizzi, E | 1 |
| Martinelli, S | 1 |
| Amore, F | 1 |
| Badii, B | 1 |
| Paolo, P | 1 |
| Ercolino, T | 1 |
| Mannelli, M | 1 |
| Maggi, M | 1 |
| Canu, L | 1 |
| Buitenwerf, E | 1 |
| Osinga, TE | 1 |
| Timmers, HJLM | 1 |
| Lenders, JWM | 1 |
| Feelders, RA | 2 |
| Eekhoff, EMW | 1 |
| Haak, HR | 1 |
| Corssmit, EPM | 1 |
| Bisschop, PHLT | 1 |
| Valk, GD | 2 |
| Veldman, RG | 1 |
| Dullaart, RPF | 1 |
| Links, TP | 1 |
| Voogd, MF | 1 |
| Wietasch, GJKG | 1 |
| Kerstens, MN | 1 |
| Kong, H | 1 |
| Li, N | 1 |
| Tian, J | 1 |
| Bao, Z | 1 |
| Liu, L | 1 |
| Wu, K | 1 |
| Gao, Y | 1 |
| Jin, B | 1 |
| Zhang, Z | 1 |
| Fang, D | 1 |
| Zhang, J | 1 |
| Zhou, L | 1 |
| Iglesias, P | 1 |
| Santacruz, E | 1 |
| García-Sancho, P | 1 |
| Marengo, AP | 1 |
| Guerrero-Pérez, F | 1 |
| Pian, H | 1 |
| Fajardo, C | 1 |
| Villabona, C | 2 |
| Díez, JJ | 1 |
| Araujo-Castro, M | 1 |
| Garcia Centeno, R | 1 |
| López-García, MC | 1 |
| Lamas, C | 1 |
| Álvarez-Escolá, C | 1 |
| Calatayud Gutiérrez, M | 1 |
| Blanco-Carrera, C | 1 |
| de Miguel Novoa, P | 1 |
| Valdés, N | 1 |
| Gracia Gimeno, P | 1 |
| Fernández-Ladreda, MT | 1 |
| Mínguez Ojeda, C | 1 |
| Percovich Hualpa, JC | 1 |
| Mora, M | 1 |
| Vidal, Ó | 1 |
| Serrano Romero, A | 1 |
| Hanzu, FA | 1 |
| Gómez Dos Santos, V | 1 |
| Suzuki, K | 1 |
| Miyake, T | 1 |
| Okada, H | 1 |
| Yamaji, F | 1 |
| Kitagawa, Y | 1 |
| Fukuta, T | 1 |
| Yasuda, R | 1 |
| Tanaka, Y | 1 |
| Okamoto, H | 1 |
| Nachi, S | 1 |
| Doi, T | 1 |
| Yoshida, T | 1 |
| Kumada, K | 1 |
| Yoshida, S | 1 |
| Ushikoshi, H | 1 |
| Toyoda, I | 1 |
| Ogura, S | 1 |
| Malec, K | 1 |
| Miśkiewicz, P | 1 |
| Witkowska, A | 1 |
| Krajewska, E | 1 |
| Toutounchi, S | 1 |
| Gałązka, Z | 1 |
| Piotrowski, M | 1 |
| Kącka, A | 1 |
| Bednarczuk, T | 1 |
| Ambroziak, U | 1 |
| Hernández-Montoliu, L | 1 |
| Simó-Servat, A | 1 |
| Conzo, G | 2 |
| Musella, M | 2 |
| Corcione, F | 2 |
| Depalma, M | 1 |
| Stanzione, F | 1 |
| Della-Pietra, C | 1 |
| Palazzo, A | 2 |
| Napolitano, S | 2 |
| Pasquali, D | 2 |
| Milone, M | 2 |
| Agostino-Sinisi, A | 1 |
| Ferraro, F | 2 |
| Santini, L | 2 |
| Matsuda, Y | 1 |
| Kawate, H | 1 |
| Shimada, S | 1 |
| Matsuzaki, C | 1 |
| Nagata, H | 1 |
| Adachi, M | 1 |
| Ohnaka, K | 1 |
| Nomura, M | 1 |
| Takayanagi, R | 1 |
| van der Zee, PA | 1 |
| de Boer, A | 1 |
| Versmissen, J | 1 |
| Koch, BC | 1 |
| Roofthooft, DW | 1 |
| Ten Bosch-Dijksman, W | 1 |
| van den Meiracker, AH | 2 |
| Hanff, LM | 1 |
| Visser, W | 1 |
| Randle, RW | 1 |
| Balentine, CJ | 1 |
| Pitt, SC | 1 |
| Schneider, DF | 1 |
| Sippel, RS | 1 |
| Amano, T | 1 |
| Imao, T | 1 |
| Takemae, K | 1 |
| Yamauchi, K | 1 |
| Bruynzeel, H | 1 |
| Groenland, TH | 1 |
| van Eijck, CH | 1 |
| Lange, JF | 1 |
| de Herder, WW | 1 |
| Kazemier, G | 1 |
| Ganesh, HK | 1 |
| Acharya, SV | 1 |
| Goerge, J | 1 |
| Bandgar, TR | 1 |
| Menon, PS | 1 |
| Shah, NS | 1 |
| Carvalho, MR | 1 |
| Dias, T | 1 |
| Rodrigues, A | 1 |
| Machado, AP | 1 |
| Esteves, R | 1 |
| do Carmo, I | 1 |
| Nakaigawa, N | 1 |
| Komatsu, R | 1 |
| Kamata, K | 1 |
| Ozaki, M | 1 |
| Zhu, Y | 1 |
| He, HC | 1 |
| Su, TW | 1 |
| Wu, YX | 1 |
| Wang, WQ | 1 |
| Zhao, JP | 1 |
| Shen, Z | 1 |
| Zhang, CY | 1 |
| Rui, WB | 2 |
| Zhou, WL | 2 |
| Sun, FK | 1 |
| Ning, G | 1 |
| Scholten, A | 1 |
| Vriens, MR | 1 |
| Cromheecke, GJ | 1 |
| Borel Rinkes, IH | 1 |
| Shao, Y | 1 |
| Chen, R | 1 |
| Shen, ZJ | 1 |
| Teng, Y | 1 |
| Huang, P | 1 |
| Xie, X | 1 |
| Groeben, H | 1 |
| Gkaliagkousi, E | 1 |
| Gavriilaki, E | 1 |
| Nikolaidou, B | 1 |
| De Palma, M | 1 |
| Sinisi, AA | 1 |
| Colantuoni, V | 1 |
| Prys-Roberts, C | 1 |
| Farndon, JR | 1 |
| Abe, M | 1 |
| Mori, K | 1 |
| Nagai, K | 1 |
| Ito, S | 1 |
| Fernández-Cruz, L | 1 |
| Puig-Domingo, M | 1 |
| Halperin, I | 1 |
| Sesmilo, G | 1 |
| Sparks, JW | 1 |
| Seefelder, C | 1 |
| Shamberger, RC | 1 |
| McGowan, FX | 1 |
| Pan, DL | 1 |
| Li, HZ | 1 |
| Ji, ZG | 1 |
| Zeng, ZP | 1 |
| Okuno, E | 1 |
| Kakinohana, M | 1 |
| Miyata, Y | 1 |
| Sugahara, K | 1 |
| Zambrana García, JL | 1 |
| Montijano Cabrera, AM | 1 |
| Adarraga Cansino, MD | 1 |
| Rosa Jiménez, F | 1 |
| Shigekawa, T | 1 |
| Sato, T | 1 |
| Mizobuchi, S | 1 |
| Nakatsuka, H | 1 |
| Yokoyama, M | 1 |
| Morita, K | 1 |
| Taylor, MJ | 1 |
| McIndoe, A | 1 |
| Mikami, H | 1 |
| Taylor, SH | 1 |
| Miura, Y | 1 |
| Yoshinaga, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| What is Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma: an Observational Study[NCT06062082] | 60 participants (Anticipated) | Observational | 2015-09-01 | Recruiting | |||
| Pheochromocytoma Randomised Study Comparing Adrenoreceptor Inhibiting Agents for Preoperative Treatment[NCT01379898] | Phase 4 | 134 participants (Actual) | Interventional | 2011-12-31 | Completed | ||
| A Pilot Study for Randomized Controlled Trial on the Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma[NCT05702944] | Phase 4 | 24 participants (Anticipated) | Interventional | 2023-01-18 | Recruiting | ||
| Clinical Study of Abandonment of Intravenous Volume Expansion After Preoperative Use of α-blockers in Patients With Adrenal Pheochromocytoma[NCT05803330] | 95 participants (Actual) | Interventional | 2014-02-20 | Completed | |||
| Randomized Controlled Trial of Preoperative Alpha Blockade for Pheochromocytoma[NCT03176693] | Phase 3 | 39 participants (Actual) | Interventional | 2017-05-05 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT03176693)
Timeframe: Preoperative (2-3 weeks prior to surgery)
| Intervention | Dollars (Median) |
|---|---|
| Phenoxybenzamine | 442.20 |
| Doxazosin | 5.06 |
"Proportion of operative time outside target thresholds: SBP >180 or <80; DBP > 90; MAP>150 or <50; HR>90.~Arterial line blood pressure measurements were extracted from the electronic medical record every 60 seconds." (NCT03176693)
Timeframe: Intraoperative, approximately 90 minutes
| Intervention | percentage of total operative time (Median) |
|---|---|
| Phenoxybenzamine | 14 |
| Doxazosin | 13 |
Morbidity will be graded by Clavien Classification of adverse events (NCT03176693)
Timeframe: Postoperatively during inpatient stay and during readmissions up to 30 days postoperatively
| Intervention | events (Number) |
|---|---|
| Phenoxybenzamine | 0 |
| Doxazosin | 0 |
Death within 30 days of surgery (NCT03176693)
Timeframe: 30 days postoperatively
| Intervention | Participants (Count of Participants) |
|---|---|
| Phenoxybenzamine | 0 |
| Doxazosin | 0 |
(NCT03176693)
Timeframe: up to 30 days post-surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Phenoxybenzamine | 2 |
| Doxazosin | 1 |
5 reviews available for doxazosin and Pheochromocytoma
| Article | Year |
|---|---|
Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Bloo | 2014 |
[Preoperative α-receptor block in patients with pheochromocytoma? Against].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Asymptomatic Diseases; Blood Pressure; Catech | 2012 |
Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; alpha-Methyltyrosine; Calcium Channel Blockers; Combined Mo | 2004 |
[Alpha-blocker].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Antihypertensive Agents; Diagnosis, Different | 1995 |
Efficacy of doxazosin in specific hypertensive patient groups.
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Cardiomegaly; Diabetes Mellitus, Type 2; Doxazosin | 1991 |
5 trials available for doxazosin and Pheochromocytoma
| Article | Year |
|---|---|
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Doxazosin; Female; Humans; Ma | 2020 |
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Doxazosin; Female; Humans; Ma | 2020 |
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Doxazosin; Female; Humans; Ma | 2020 |
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Doxazosin; Female; Humans; Ma | 2020 |
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Doxazosin; Female; Humans; Ma | 2020 |
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Doxazosin; Female; Humans; Ma | 2020 |
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Doxazosin; Female; Humans; Ma | 2020 |
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Doxazosin; Female; Humans; Ma | 2020 |
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Blood Pressure; Doxazosin; Female; Humans; Ma | 2020 |
Perioperative sequential monitoring of hemodynamic parameters in patients with pheochromocytoma using the Non-Invasive Cardiac System (NICaS).
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Antihypertensive Agents; Doxazosin; Female; Hem | 2014 |
Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antag | 2010 |
Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Dose | 2002 |
Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Dose | 2002 |
Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Dose | 2002 |
Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Dose | 2002 |
Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Catecho | 1988 |
27 other studies available for doxazosin and Pheochromocytoma
| Article | Year |
|---|---|
Comparison of Preoperative Alpha-blockade for Resection of Paraganglioma and Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Case-Control Studies; Doxazosin; Humans; Phen | 2022 |
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study.
Topics: Adrenal Gland Neoplasms; Catecholamines; Doxazosin; Female; Hemodynamics; Humans; Male; Middle Aged; | 2023 |
The use of doxazosin before adrenalectomy for pheochromocytoma: is the duration related to intraoperative hemodynamics and postoperative complications?
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Doxazo | 2020 |
Pheochromocytoma: A three-decade clinical experience in a multicenter study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Age | 2021 |
Risk factors for intraoperative complications in pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Doxazosin; Female; Humans; Hydrocortisone; Hypo | 2021 |
Thyrotoxic and pheochromocytoma multisystem crisis: a case report.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Antagonists; Carbazoles; Carvedilol; Diagnosis, | 2017 |
Comparison of phenoxybenzamine and doxazosin in perioperative management of patients with pheochromocytoma.
Topics: Adrenalectomy; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Disease Mana | 2017 |
Tako-Tsubo cardiomyopathy induced by pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aged; Atrial Fibrillation; Diagnosis, Differential; Doxazosi | 2018 |
Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma: a retrospective study of 48 cases.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-1 Receptor Antagonists; Adult; Age Factors; | 2013 |
Doxazosin treatment of phaeochromocytoma during pregnancy: placental transfer and disposition in breast milk.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Doxazosin; Female; Humans; Infant, New | 2016 |
Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Female; | 2017 |
Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Female; | 2017 |
Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Female; | 2017 |
Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Female; | 2017 |
[Ejaculatory disorder caused by doxazosin administration for blood pressure control in patient with pheochomocytoma].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Doxazosin; Ej | 2009 |
Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Blood Pressure; Catecholamines; | 2010 |
Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Blood Pressure; Catecholamines; | 2010 |
Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Blood Pressure; Catecholamines; | 2010 |
Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Blood Pressure; Catecholamines; | 2010 |
Pheochromocytoma in children and adolescents.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-Antagonists; Child; Doxazosin; | 2009 |
Alpha blockade with doxazosin in pheochromocytoma--report of three cases.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Doxazosin; Female; Humans; Middl | 2010 |
[Anesthetic management of a patient with pheochromocytoma and end-stage renal disease].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Anesthesia, General; Cervical Vertebrae; Chro | 2010 |
Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagon | 2011 |
Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary?
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Doxazos | 2011 |
Clarifying the role of preoperative α-blockade in pheochromocytoma?
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Doxazosin; Female; Humans; Intraoperative Com | 2012 |
Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-1 Receptor Antagonists; Adult; Doxazosin; F | 2013 |
Relapse of Graves' disease in a patient with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antithyroid Agen | 2003 |
The perioperative management of a patient with complex single ventricle physiology and pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Anesthesia; Blood Pressure; Double Out | 2005 |
[Effects of doxazosin mosylate and phenoxybenzamine in preoperative volume expansion of pheochromocytoma: a comparative study in 38 cases].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Blood Volume; Doxazosin; Drug Ad | 2005 |
[Anesthetic management for off-pump coronary artery bypass grafting in a patient with a pheochromocytoma and followed by the resection of the pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Anesthesia, Epidural; Anesthesia, Inhalation; | 2007 |
[Recurrent syncopes secondary to pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Aged; Amlodipine; Antihypertensive Agents; Do | 2007 |
[Perioperative treatment of a patient with ectopic ACTH-producing pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Anesthesia, Epid | 2007 |
Unresponsive asystolic cardiac arrest responding to external cardiac pacing in a patient with phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Cardiac Pacing, Artificial; Doxazosin; Female | 2007 |